lapatinib has been researched along with pd168393 in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (pd168393) | Trials (pd168393) | Recent Studies (post-2010) (pd168393) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 61 | 0 | 33 |
| Protein | Taxonomy | lapatinib (IC50) | pd168393 (IC50) |
|---|---|---|---|
| Proto-oncogene tyrosine-protein kinase Src | Gallus gallus (chicken) | 1.0702 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 0.0143 | |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 0.0334 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 0.1543 | |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.073 | |
| Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (human) | 0.0011 | |
| Tyrosine-protein kinase Blk | Homo sapiens (human) | 5.47 | |
| Cytoplasmic tyrosine-protein kinase BMX | Homo sapiens (human) | 0.5757 | |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | 3.14 | |
| Tyrosine-protein kinase BTK | Homo sapiens (human) | 5.83 | |
| Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | 0.0047 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Da Settimo, F; La Motta, C; Martinelli, A; Nerini, E; Sartini, S; Tuccinardi, T | 1 |
1 other study(ies) available for lapatinib and pd168393
| Article | Year |
|---|---|
Computational studies of epidermal growth factor receptor: docking reliability, three-dimensional quantitative structure-activity relationship analysis, and virtual screening studies.
Topics: Computational Biology; Computer Simulation; Databases, Protein; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Protein Binding; Quantitative Structure-Activity Relationship | 2009 |